IBRXImmunityBio, Inc.Mar 3, 2026Q4 2025
Read transcript →ImmunityBio, Inc. (IBRX) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$8.65
+10.69%
Mkt Cap $8.81B
IBRXImmunityBio, Inc.Mar 3, 2026IBRXImmunityBio, Inc.Mar 3, 2026NASDAQ·Healthcare·Biotechnology
$8.65
+10.69%
Mkt Cap $8.81B
IBRXImmunityBio, Inc.Mar 3, 2026Q4 2025
Read transcript →